Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.
Metrics to compare | 002620 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002620PeersSector | |
---|---|---|---|---|
P/E Ratio | −2.7x | 9.1x | −0.5x | |
PEG Ratio | 0.03 | 0.01 | 0.00 | |
Price/Book | 0.4x | 0.9x | 2.6x | |
Price / LTM Sales | 0.2x | 0.6x | 3.3x | |
Upside (Analyst Target) | - | 52.2% | 42.9% | |
Fair Value Upside | Unlock | 32.7% | 6.2% | Unlock |